Research and development on bio-enabling formulations as part of the EU-project PEARRL
The PEARRL (Pharmaceutical Education And Research with Regulatory Links) project is a European Training Network (ETN) and is funded under the European Union’s Horizon 2020 research and innovation programme (Marie Sklodowska-Curie actions). There are nine beneficiaries as well about the same number of partner organizations.
In PEARRL, young researchers will work together with experienced academic, industrial and regulatory scientists to develop innovative formulation strategies for promising drugs so that they can be brought to market, and to create robust biopharmaceutics tools that can facilitate faster approval of new drugs by regulatory authorities.
The University of Applied Sciences and Arts Northwestern Switzerland (FHNW) has the lead on the bio-enabling formulation work package and a particular focus is on lipid-based formulations as well as on amorphous solid dispersions. Apart from novel oral formulations, the project also develops new computational and in vitro tools to support formulation development.
Project details
- Type
- Research project
- Research areas
- Oral formulations of chemical drugs
- University
- FHNW School of Life Sciences / Institute for Pharma Technology and Biotechnology
- Partner
- Johann Wolfgang Goethe University, DE; National and Kapodestrian University of Athens, GR; University of Bath, UK; Merck KGaA, DE; Pharmathen SA, GR; Sirius Analytical Ltd, UK; Janssen Pharmaceutica N.V., BE; accelopment Schweiz AG, CH
- Funding
- Horizon 2020 - Marie Sklodowska-Curie
- Running time
- 2016-2020
Contact
Prof. Dr. Martin Kuentz
- Phone
- +41 61 228 56 42
- martin.kuentz@fhnw.ch